Pathogenesis and management of nasal polyposis in cystic fibrosis

Current Allergy and Asthma Reports

Volumn 12, Issue 2, 2012, Pages 163-174

  Mainz, Jochen G ^a   Koitschev, Assen ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b KLINIKUM STUTTGART   (Germany)

Author keywords

Antibiotics; Cystic fibrosis; FESS; IL 8; Inflammation; Interleukins; Macrolides; Mucociliary clearance; Mucolytics; Nasal lavage; Nasal polyposis; Neutrophil; Nose; Ostiomeatal complex; Pathogen colonization; Pseudomonas aeruginosa; Quality of life; Rhinoscopy; Rhinosinusitis; Sinonasal inhalation; Sinonasal surgery; Staphylococcus aureus; Steroids; Topical therapy; Upper airways

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BETAMETHASONE; COLISTIN; DORNASE ALFA; IBUPROFEN; IMMUNOMODULATING AGENT; MACROLIDE; MEPOLIZUMAB; PLACEBO; STEROID; TOBRAMYCIN;

ARTICLE; CHRONIC RHINOSINUSITIS; CONSERVATIVE TREATMENT; CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EPISTAXIS; HUMAN; LOW DRUG DOSE; LUNG DISEASE; NASAL LAVAGE; NOSE POLYP; NOSE SURGERY; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT CARE; TREATMENT RESPONSE; CHRONIC DISEASE; NOMENCLATURE; RHINITIS; SINUSITIS; ENDOSCOPY; METABOLISM; METHODOLOGY; MUCOCILIARY CLEARANCE; NOSE MUCOSA; REVIEW; TOPICAL DRUG ADMINISTRATION;

CHRONIC DISEASE; CYSTIC FIBROSIS; HUMANS; NASAL LAVAGE; NASAL POLYPS; RHINITIS; SINUSITIS; TERMINOLOGY AS TOPIC; ADMINISTRATION, TOPICAL; DIAGNOSTIC IMAGING; ENDOSCOPY; MUCOCILIARY CLEARANCE; NASAL MUCOSA; STEROIDS;

EID: 84861235685     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-012-0250-y     Document Type: Article

References (100)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066-73. (Pubitemid 19231814)
2. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073-80. (Pubitemid 19231815)
3. Eggesbo HB, Sovik S, Dolvik S, Eiklid K, Kolmannskog F. CT characterization of developmental variations of the paranasal sinuses in cystic fibrosis. Acta Radiol. 2001;42:482-93. (Pubitemid 33655091)
4. King VV. Upper respiratory disease, sinusitis, and polyposis. Clin Rev Allergy. 1991;9:143-57.
5. Koitschev A, Wolff A, Koitschev C, Preyer S, Ziebach R, Stern M. Routine otorhinolaryngological examination in patients with cystic fibrosis. HNO. 2006;54:361-4. 366, 368.
6. Robertson JM, Friedman EM, Rubin BK. Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev. 2008;9:213-9.
7. Feuillet-Fieux MN, Lenoir G, Sermet I, Elie C, Djadi-Prat J, Ferrec M, et al. Nasal polyposis and cystic fibrosis(CF): review of the literature. Rhinology. 2011;49:347-55.
8. Kingdom TT, Lee KC, FitzSimmons SC, Cropp GJ. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery. Arch Otolaryngol Head Neck Surg. 1996;122:1209-13. (Pubitemid 26374848)
9. Henriksson G, Westrin KM, Karpati F, Wikstrom AC, Stierna P, Hjelte L. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest. 2002;121:40-7. (Pubitemid 34114226)
10. De Gaudemar I, Contencin P, Van den Abbeele T, Munck A, Navarro J, Narcy P. Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection? Rhinology. 1996;34:194-7. (Pubitemid 27090592)
11. Cimmino M, Cavaliere M, Nardone M, Plantulli A, Orefice A, Esposito V, et al. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis. Clin Otolaryngol Allied Sci. 2003;28:125-32. (Pubitemid 36514149)
12. Hadfield PJ, Rowe-Jones JM, Mackay IS. The prevalence of nasal polyps in adults with cystic fibrosis. Clin Otolaryngol Allied Sci. 2000;25:19-22. (Pubitemid 30137850)
13. FokkensW, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy. 2005;60:583-601. (Pubitemid 40562464)
14. Gysin C, Alothman GA, Papsin BC. Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol. 2000;30:481-9.
15. Drake-Lee AB, Morgan DW. Nasal polyps and sinusitis in children with cystic fibrosis. J Laryngol Otol. 1989;103:753-5. (Pubitemid 19204322)
16. Babinski D, Trawinska-Bartnicka M. Rhinosinusitis in cystic fibrosis: not a simple story. Int J Pediatr Otorhinolaryngol. 2008;72:619-24.
17. Jorissen MB, De Boeck K, Cuppens H. Genotype-phenotype correlations for the paranasal sinuses in cystic fibrosis. Am J Respir Crit Care Med. 1999;159:1412-6. (Pubitemid 29227846)
18. Newton JR, Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag. 2008;4:507-12. (Pubitemid 351712010)
19. Taylor RF, Morgan DW, Nicholson PS, Mackay IS, Hodson ME, Pitt TL. Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis. Thorax. 1992;47:426-8.
20. Mainz JG, Naehrlich L, Schien M, KadingM, Schiller I,Mayr S, et al. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax. 2009;64:535-40. This study provided proof of the cross-relation of upper and lower airways ("one airway hypothesis") by genotypically identical P. aeruginosa clones in CF upper and lower airways. It also identified NL as the most sensitive method to sample the upper airways.
21. Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361:681-9. (Pubitemid 36246556)
22. Schraven SP, Wehrmann M, Wagner W, Blumenstock G, Koitschev A. Prevalence and histopathology of chronic polypoid sinusitis in pediatric patients with cystic fibrosis. J Cyst Fibros. 2011;10:181-6. This article provided a histologic comparison of CF to non-CF NP, identifying abundant mucus glands in CF-NP with mucus retention.
23. Knipping S, Holzhausen HJ, Riederer A, Bloching M. Cystic fibrosis: ultrastructural changes of nasal mucosa. Eur Arch Otorhinolaryngol. 2007;264:1413-8. (Pubitemid 350119681)
24. Bergoin C, Gosset P, Lamblin C, Bolard F, Turck D, Tonnel AB, et al. Cell and cytokine profile in nasal secretions in cystic fibrosis. J Cyst Fibros. 2002;1:110-5.
25. Beju D, Meek WD, Kramer JC. The ultrastructure of the nasal polyps in patients with and without cystic fibrosis. J Submicrosc Cytol Pathol. 2004;36:155-65. (Pubitemid 39524161)
26. Henderson Jr WR, Chi EY. Degranulation of cystic fibrosis nasal polyp mast cells. J Pathol. 1992;166:395-404.
27. Rowe-Jones JM, Shembekar M, Trendell-Smith N, Mackay IS. Polypoidal rhinosinusitis in cystic fibrosis: a clinical and histopathological study. Clin Otolaryngol Allied Sci. 1997;22:167-71. (Pubitemid 28351786)
28. Claeys S, Van Hoecke H, Holtappels G, Gevaert P, De Belder T, Verhasselt B, et al. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy. 2005;35:467-72. (Pubitemid 40577239)
29. Derycke L, Zhang N, Holtappels G, Dutre T, Bachert C. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis. J Cyst Fibros. 2011. doi:10.1016/j/jcf.2011.11.007
30. Rachelefsky GS, Osher A, Dooley RE, Ank B, Stiehm ER. Coexistent respiratory allergy and cystic fibrosis. Am J Dis Child. 1974;128:355-9.
31. Biewenga J, Stoop AE, Baker HE, Swart SJ, Nauta JJ, van Kamp GJ, et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem. 1991;28(Pt 3):260-6.
32. Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis. 1997;175:638-47. (Pubitemid 27086168)
33. Wang D, Brihaye P, Smitz J, De Waele M, Clement P. Inflammatory cells and mediator concentrations in nasal secretions of patients with cystic fibrosis. Acta Otolaryngol. 1996;116:472-6. (Pubitemid 26183107)
34. Lesprit E, Escudier E, Roger G, Pruliere V, Lenoir G, Reinert P, et al. Characterization of inflammatory reaction in upper airways of cystic fibrosis patients. Histol Histopathol. 2000;15:395-402. (Pubitemid 30218832)
35. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151:1075-82.
36. Wolter JM, Rodwell RL, Bowler SD, McCormack JG. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. Clin Diagn Lab Immunol. 1999;6:260-5. (Pubitemid 29124975)
37. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993; 31:183-4. (Pubitemid 24049736)
38. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117:S35-40. (Pubitemid 27435427)
39. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104-9.
40. Eggesbo HB, Dolvik S, Stiris M, Sovik S, Storrosten OT, Kolmannskog F. Complementary role of MR imaging of ethmomaxillary sinus disease depicted at CT in cystic fibrosis. Acta Radiol. 2001;42:144-50. (Pubitemid 33655037)
41. Mainz JG, Koitschev A. Management of chronic rhinosinusitis in CF. J Cyst Fibros. 2009;8 Suppl 1:S10-4.
42. Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database Syst Rev. 2011;CD005232.
43. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;CD006394.
44. Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope. 1997;107:500-3. (Pubitemid 27176059)
45. Bachmann G, Hommel G, Michel O. Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol. 2000;257:537-41. (Pubitemid 32009705)
46. Wormald PJ, Cain T, Oates L, Hawke L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004; 114:2224-7. (Pubitemid 39602494)
47. Moller W, Schuschnig U, Meyer G, Mentzel H, Keller M. Ventilation and drug delivery to the paranasal sinuses: studies in a nasal cast using pulsating airflow. Rhinology. 2008;46:213-20.
48. Moller W, Schuschnig U, Khadem Saba G, Meyer G, Junge- Hulsing B, Keller M, et al. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers. Otolaryngol Head Neck Surg. 2010;142:382-8. This study provided proof of deposition of vibrating aerosols into paranasal sinuses in vivo by scintigraphy, which is not achieved in nasal inhalation without pulsation or by nasal sprays or drops.
49. Mainz JG, Schiller I, Ritschel C, Mentzel HJ, Riethmuller J, Koitschev A, et al. Sinonasal inhalation of dornase alfa in CF: a double-blind placebo-controlled cross-over pilot trial. Auris Nasus Larynx. 2011;38:220-7. This was the first study to assess sinonasal inhalation with vibrating aerosols in CRS patients with significantly positive results in SNOT-20 already in the pilot trial.
50. Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet. 1993; 341:1065-9. (Pubitemid 23114408)
51. Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax. 1996;51:119-25. (Pubitemid 26060647)
52. Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2010;CD001127.
53. Raynor EM, Butler A, Guill M, Bent 3rd JP. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2000;126:581-3. (Pubitemid 30252929)
54. Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch Otolaryngol Head Neck Surg. 2005;131(12):1097-101. (Pubitemid 41815885)
55. Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2009;CD001506. This article discusses the significant effects of bronchial inhalation of hypertonic saline in CF
56. Burgel PR, Cardell LO, Ueki IF, Nadel JA. Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps. Eur Respir J. 2004;24:594-600. (Pubitemid 39406133)
57. Lund VJ, Flood J, Sykes AP, Richards DH. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg. 1998;124:513-8. (Pubitemid 28222339)
58. ThomasM, Yawn BP, Price D, LundV, Mullol J, FokkensW. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007 - a summary. Prim Care Respir J. 2008;17:79-89. (Pubitemid 351847085)
59. Donaldson JD, Gillespie CT. Observations on the efficacy of intranasal beclomethasone dipropionate in cystic fibrosis patients. J Otolaryngol. 1988;17:43-5. (Pubitemid 18069342)
60. Costantini D, Di Cicco M, Giunta A, Amabile G. Nasal polyposis in cystic fibrosis treated by beclomethasone dipropionate. Acta Univ Carol Med. 1990;36:220-1.
61. Beer H, Southern KW, Swift AC. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. Cochrane Database Syst Rev. 2011;CD008253. This is a review on TS therapy in CF-NP.
62. Stern RC, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child. 1982;136:1067-70. (Pubitemid 13243775)
63. Hadfield PJ, Rowe-Jones JM, Mackay IS. A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology. 2000;38:63-5. (Pubitemid 30433468)
64. Davidson TM, Murphy C, Mitchell M, Smith C, Light M. Management of chronic sinusitis in cystic fibrosis. Laryngoscope. 1995;105:354-8.
65. Moss RB, King VV. Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg. 1995;121:566-72.
66. Graham SM, Launspach JL, Welsh MJ, Zabner J. Sequential magnetic resonance imaging analysis of the maxillary sinuses: implications for a model of gene therapy in cystic fibrosis. J Laryngol Otol. 1999;113:329-35. (Pubitemid 29191793)
67. Ryan G, Singh M, Dwan K. Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev. 2011; CD001021. This article provides proof of the therapeutic effect and safety of bronchial antibiotic inhalation in CF lung disease.
68. Mainz JG, Schien C, Schädlich K, Pfister W, Schelhorn- Neise P, Koitschev A, et al. Sinonasal inhalation of Tobramycin in CF-patients with P. aeruginosa-colonization of the upper airways - results of a multicentric placebo controlled pilot study - Oral and poster: 34rd European Cystic Fibrosis Conference, 06.2011, Hamburg. J Cyst Fibros. 2011;10S:21.
69. Mainz JG, Michl R, Pfister W, Beck JF. Cystic Fibrosis Upper Airways Primary Colonization with P. aeruginosa: Eradicated by Sinonasal Antibiotic Inhalation. Am J Respir Crit Care Med. 2011;184(9):1089-90.
70. Mainz JG, Hentschel J, Schien C, Cramer N, Pfister W, Beck JF, Tümmler B. P. aeruginosa persists in the upper airways after lung transplantation. J Cyst Fibros. 2011. doi:10.1016/j.jcf.2011.10.009.
71. Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet. 1998;351:420. (Pubitemid 28064175)
72. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med. 2004;117 (Suppl 9A):5S-11S.
73. Nonaka M, Pawankar R, Tomiyama S, Yagi T. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol. 1999;13:267-72.
74. Suzuki H, Shimomura A, Ikeda K, Furukawa M, Oshima T, Takasaka T. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope. 1997;107:1661-6. (Pubitemid 27520179)
75. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol. 2000;14:143-8. (Pubitemid 30441214)
76. Videler WJ, Badia L, Harvey RJ, Gane S, Georgalas C, van der Meulen FW, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66:1457-68.
77. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of highdose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995;332:848-54.
78. Lindstrom DR, Conley SF, Splaingard ML, Gershan WM. Ibuprofen therapy and nasal polyposis in cystic fibrosis patients. J Otolaryngol. 2007;36:309-14. (Pubitemid 350114713)
79. Mainz JG, Schien M, Naehrlich L, Käding M, Thoss K, Frey G, et al. Prevalence of CF-related chronic rhinosinusitis - results from a multicentre interdisciplinary study. In 33rd European Cystic Fibrosis Conference; 2010. J Cyst Fibros. 2010:9 S1, 118.
80. Beata RN, Wojciech F, Stanislaw S, Ryszard M. The influence of anti-inflammatory drugs on the proliferation of fibroblast derived from nasal polyps. Auris Nasus Larynx. 2005;32:225-9. (Pubitemid 41058734)
81. Saji F, Nonaka M, Pawankar R. Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts. Auris Nasus Larynx. 2000;27:247-52. (Pubitemid 30251878)
82. Hamilos DL, Leung DY, Huston DP, Kamil A, Wood R, Hamid Q. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy. 1998;28:1145-52. (Pubitemid 28432638)
83. Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128:989-95. e981-988.
84. Schulte DL, Kasperbauer JL. Safety of paranasal sinus surgery in patients with cystic fibrosis. Laryngoscope. 1998;108:1813-5. (Pubitemid 28559664)
85. Messerklinger W. Background and evolution of endoscopic sinus surgery. Ear Nose Throat J. 1994;73:449-50. (Pubitemid 24223969)
86. Keck T, Rozsasi A. Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope. 2007;117:475-9. (Pubitemid 46407757)
87. Rickert S, Banuchi VE, Germana JD, Stewart MG, April MM. Cystic fibrosis and endoscopic sinus surgery: relationship between nasal polyposis and likelihood of revision endoscopic sinus surgery in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2010;136:988-92. This is an analysis of recurrences after CF-NP surgery.
88. Madonna D, Isaacson G, Rosenfeld RM, Panitch H. Effect of sinus surgery on pulmonary function in patients with cystic fibrosis. Laryngoscope. 1997;107:328-31. (Pubitemid 27147499)
89. Osborn AJ, Leung R, Ratjen F, James AL. Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis. Arch Otolaryngol Head Neck Surg. 2011;137:542-7. This article provides retrospective identification of lacking effects of sinonasal surgery in CF on pulmonary function, which requires further prospective investigation.
90. Kayarkar R, Clifton NJ, Woolford TJ. An evaluation of the best head position for instillation of steroid nose drops. Clin Otolaryngol Allied Sci. 2002;27:18-21. (Pubitemid 34264426)
91. Raghavan U, Jones NS. A prospective randomized blinded crossover trial using nasal drops in patients with nasal polyposis: an evaluation of effectiveness and comfort level of two head positions. Am J Rhinol. 2006;20:397-400. (Pubitemid 44390214)
92. Johansson L, Oberg D, Melen I, Bende M. Do topical nasal decongestants affect polyps? Acta Otolaryngol. 2006;126:288-90. (Pubitemid 43259233)
93. Graf PM. Rhinitis medicamentosa. Clin Allergy Immunol. 2007; 19:295-304.
94. Helbling A, Baumann A, Hanni C, Caversaccio M. Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol. 2006;120:1023-5. (Pubitemid 46132584)
95. Heintz B, Schlenter WW, Kirsten R, Nelson K. Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis-a multi-centric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol. 1989;27:530-4. (Pubitemid 20006825)
96. Cuyler JP. Follow-up of endoscopic sinus surgery on children with cystic fibrosis. Arch Otolaryngology Head Neck Surg. 1992;118:505-6.
97. Nishioka GJ, Barbero GJ, Konig P, Parsons DS, Cook PR, Davis WE. Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol Head Neck Surg. 1995;113:440-5.
98. Coste A, Idrissi F, Beautru R, Lenoir G, Reinert P, Manach Y, et al. Endoscopic endonasal ethmoidectomy in severe sinusitis of cystic fibrosis. Mid-term results in 12 patients. Ann Otolaryngol Chir Cervicofac. 1997;114(4):99-104.
99. Triglia JM, Nicollas R. Nasal and sinus polyposis in children. Laryngoscope. 1997;107:963-6. (Pubitemid 27284327)
100. Yung MW, Gould J, Upton GJ. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol. 2002;111:1081-6. (Pubitemid 36020181)